← Leaderboards
Bradley David Gelfand
University Of Virginia
$8,956,117
Attributed
$13,811,328
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,811,328 · 6
By mechanism
R01$13,811,328 · 6
Top collaborators
- Jayakrishna Ambati21 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Heather Ferris$3,019,792
- Noelle D Dwyer$7,701,237
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposPathway InteractionsSignal TransductionCellsInsightBlood VesselsPathologicExhibitsAffectCell TypeMolecularPathologyAge Related Macular DegenerationS DiseasePathogenesisRetinaImmuneRetinal DiseasesDiabetic RetinopathyCytokineGeneticMediatingMouse ModelInflammasome
Grant awards (29)
Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation$658,142
R01 · FY2025 · HL · contact PI
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina$614,163
R01 · FY2025 · AG
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease$608,367
R01 · FY2025 · AG
Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation$651,084
R01 · FY2024 · HL · contact PI
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina$631,751
R01 · FY2024 · AG
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease$620,783
R01 · FY2024 · AG
DICER1 deficiency in aberrant chorioretinal neovascularization$510,360
R01 · FY2024 · EY · contact PI
Nlrp3 inflammasome activation in early diabetic retinopathy$472,784
R01 · FY2024 · EY
Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation$689,930
R01 · FY2023 · HL · contact PI
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina$626,696
R01 · FY2023 · AG
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease$620,783
R01 · FY2023 · AG
DICER1 deficiency in aberrant chorioretinal neovascularization$510,360
R01 · FY2023 · EY · contact PI
Nlrp3 inflammasome activation in early diabetic retinopathy$472,784
R01 · FY2023 · EY
Visual system and cognitive biology in normal animals versus in an animal model of Alzheimer's disease with or without diabetes treated with solo or dual inflammasome inhibitors$403,750
R01 · FY2023 · EY
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease$620,783
R01 · FY2022 · AG
DICER1 deficiency in aberrant chorioretinal neovascularization$495,049
R01 · FY2022 · EY · contact PI
Nlrp3 inflammasome activation in early diabetic retinopathy$458,602
R01 · FY2022 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$391,639
R01 · FY2022 · EY
DICER1 deficiency in aberrant chorioretinal neovascularization - Administrative Supplement OKT Request$60,245
R01 · FY2022 · EY · contact PI
Nlrp3 inflammasome activation in early diabetic retinopathy - Administrative Supplement ERG Request$52,750
R01 · FY2022 · EY
DICER1 deficiency in aberrant chorioretinal neovascularization$525,735
R01 · FY2021 · EY · contact PI
Nlrp3 inflammasome activation in early diabetic retinopathy$462,151
R01 · FY2021 · EY
Inflammasome-based Alzheimer's disease therapy in the context of diabetes$403,748
R01 · FY2021 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$391,639
R01 · FY2021 · EY
Nlrp3 inflammasome activation in early diabetic retinopathy$484,500
R01 · FY2020 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$403,750
R01 · FY2020 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$403,750
R01 · FY2019 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$161,500
R01 · FY2019 · EY
Antigen-independent suppression of ocular angiogenesis via the Fc receptor$403,750
R01 · FY2018 · EY